Cercano Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Cercano Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4M	Hold	7,172,985	–	–	1.79%	9
2026 Q1	$27.8M	Hold	7,172,985	–	–	1.2%	19
2025 Q4	$14M	Hold	7,172,985	–	–	0.53%	42
2025 Q3	$6.06M	Hold	7,172,985	–	–	0.23%	65
2025 Q2	$5.2M	Hold	7,172,985	–	–	0.15%	69
2025 Q1	$6.18M	Hold	7,172,985	–	–	0.18%	63
2024 Q4	$12.1M	Hold	7,172,985	–	–	0.31%	61
2024 Q3	$20.4M	Hold	7,172,985	–	–	0.49%	47
2024 Q2	$16.8M	Hold	7,172,985	–	–	0.45%	50
2024 Q1	$21.1M	Hold	7,172,985	–	–	0.59%	44
2023 Q4	$21.4M	Hold	7,172,985	–	–	0.71%	38
2023 Q3	$22.7M	Hold	7,172,985	–	–	0.81%	36
2023 Q2	$27.8M	Hold	7,172,985	–	–	0.96%	26
2023 Q1	$19.9M	Hold	7,172,985	–	–	0.79%	26
2022 Q4	$12.9M	Buy	+7,172,985	New	+$13.8M	0.52%	45

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cercano Management's NAUT Position: Q2 2026 in Review

Cercano Management held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 7,172,985 shares worth $13.4M. The position accounts for 1.79% of the portfolio, ranked #9.

Cercano Management first reported a position in NAUT in Q4 2022 and has held it in 15 quarters since. The position peaked at $27.8M in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Cercano Management held 7,172,985 shares of Nautilus Biotechnolgy worth $13.4M as of Q2 2026.
Cercano Management left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
Nautilus Biotechnolgy made up 1.79% of Cercano Management's portfolio in Q2 2026, its #9 holding.
Cercano Management first reported a position in Nautilus Biotechnolgy in Q4 2022 and has held it in 15 quarters since.
Cercano Management's Nautilus Biotechnolgy position peaked at $27.8M in Q1 2026.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Cercano Management's 13F filing for Q2 2026, filed 13 Aug 2026.